Agonist binding to β-adrenergic receptors on human airway epithelial cells inhibits migration and wound repair.
Human airway epithelial cells express β-adrenergic receptors (β-ARs), which regulate mucociliary clearance by stimulating transepithelial anion transport and ciliary beat frequency. Previous studies using airway epithelial cells showed that stimulation with isoproterenol increased cell migration and wound repair by a cAMP-dependent mechanism. In the present study, impedance-sensing arrays were used to measure cell migration and epithelial restitution following wounding of confluent normal human bronchial epithelial (NHBE) and Calu-3 cells by electroporation. Stimulation with epinephrine or the β2-AR-selective agonist salbutamol significantly delayed wound closure and reduced the mean surface area of lamellipodia protruding into the wound. Treatment with the β-AR bias agonist carvedilol or isoetharine also produced a delay in epithelial restitution similar in magnitude to epinephrine and salbutamol. Measurements of extracellular signal-regulated kinase phosphorylation following salbutamol or carvedilol stimulation showed no significant change in the level of phosphorylation compared with untreated control cells. However, inhibition of protein phosphatase 2A activity completely blocked the delay in wound closure produced by β-AR agonists. In Calu-3 cells, where CFTR expression was inhibited by RNAi, salbutamol did not inhibit wound repair, suggesting that β-AR agonist stimulation and loss of CFTR function share a common pathway leading to inhibition of epithelial repair. Confocal images of the basal membrane of Calu-3 cells labeled with anti-β1-integrin (clone HUTS-4) antibody showed that treatment with epinephrine or carvedilol reduced the level of activated integrin in the membrane. These findings suggest that treatment with β-AR agonists delays airway epithelial repair by a G protein- and cAMP-independent mechanism involving protein phosphatase 2A and a reduction in β1-integrin activation in the basal membrane.
Department of Animal Science, University of Minnesota, St. Paul, Minnesota; and.
Elizabeth R
ER
Peitzman
Department of Integrative Biology and Physiology, University of Minnesota, St. Paul, Minnesota.
Nathan A
NA
Zaidman
Department of Animal Science, University of Minnesota, St. Paul, Minnesota; and.
Peter J
PJ
Maniak
Department of Animal Science, University of Minnesota, St. Paul, Minnesota; and Department of Integrative Biology and Physiology, University of Minnesota, St. Paul, Minnesota ograd001@umn.edu.
Scott M
SM
O'Grady
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D002460:Cell Line; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology*; D018274:Electroporation; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007150:Immunohistochemistry; D018613:Microscopy, Confocal; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*; D020545:Respiratory Mucosa / Q000378:metabolism*; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology*
D000318:Adrenergic beta-Agonists; D011943:Receptors, Adrenergic, beta
biased agonism; carvedilol; epinephrine; impedance sensing; β-arrestin signaling